Skip to content

The African Critical Illness Outcomes Study

The African Critical Illness Outcomes Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06051526
Acronym
ACIOS
Enrollment
20159
Registered
2023-09-25
Start date
2023-09-01
Completion date
2024-01-03
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Mortality

Brief summary

In Africa, the prevalence of critical illness is likely to be higher due to a greater burden of disease, and the associated mortality higher due to limited resources. This is a prospective, observational study to rapidly establish the prevalence of critical illness in in-hospital adult patients in Africa, and the resources available to provide essential critical care (care that should be available to every patient in the world) and factors associated with mortality. Rapid dissemination of these findings may help mitigate mortality from critical illness in Africa. These points provide the rationale for the African Critical Illness Outcomes Study.

Detailed description

STUDY OBJECTIVES The objectives of this study are to determine: 1. The proportion of hospital patients who are critically ill, 2. The mortality associated with critical illness, 3. The proportion of critically ill patients who receive essential emergency and critical care, 4. The relationship between essential emergency and critical care provision, and mortality, and 5. The availability of resources necessary to provide essential emergency and critical care. STUDY DESIGN An African multi-centre prospective observational cohort study of adult (≥18 years) in-hospital patients. Patient follow up will be for a maximum of 7 days in-hospital. The primary outcome is in-hospital mortality in adult hospital patients with and without critical illness in Africa. The intention is to provide a representative sample of the mortality, the risk factors associated with mortality in adult patients with critical illness, and the resources available and interventions provided to treat critical illness in Africa. This study will run between September and November 2023. PREPARATORY WORK This study will be run by the African Perioperative Research Group (APORG), with a network of over 600 hospitals in more than 40 African countries which has successfully conducted the African Surgical Outcomes Study (ASOS), the ASOS-2 Trial, the African COVID-19 Critical Care Outcomes Study (ACCCOS) and the African Pediatric Surgical Outcomes Study (ASOS-PEDS). IMPORTANCE OF THIS STUDY To decrease the mortality associated with critical illness in Africa, it is important to rapidly establish the potential risk factors for mortality, and resources available to manage these patients. The APORG network has the capacity to provide these data timeously.

Interventions

None listed

Sponsors

Muhimbili University of Health and Allied Sciences
CollaboratorOTHER
University of Cape Town
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* All adult patients aged 18 years or over who have been admitted for inpatient care in any department or ward in participating hospitals.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Presence of critical illness7 daysThe number of participants with critical illness.
In-hospital mortality (censored at 7-days)7 daysThe number of participants with in-hospital mortality (censored at 7-days)

Secondary

MeasureTime frameDescription
Provision of essential emergency and critical care7 daysTo number of critically ill patients who receive essential emergency and critical care.
Length of hospital stay7 daysThe length of hospital stay for critically ill patients
Number of essential emergency and critical care resources available for care7 daysThe number of essential emergency and critical care resources available

Countries

Sudan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026